Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,663 signal articles · 35 in last 24h · 155,967 total before filter · latest 28m ago
35last 24h
852last 7d
149● bullish (7d)
87● bearish (7d)
214publishers
AllMacro190Earnings110M&A124Regulatory19Product19Analyst21
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
Insider Monkey30d agobullish
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?

Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck. The companies said their Phase 3 INTerpath-001 trial met its recurrence-free survival endpoint for the personalized cancer therapy intismeran autogene, also known as V940, combined with Keytruda. Detailed trial data remain pending. The read-through came from Personalis, which has supported the […]

Strategy (MSTR) Rallies with Bitcoin. Is the Leverage Still Worth the Complexity?
Insider Monkey30d agobullish
Strategy (MSTR) Rallies with Bitcoin. Is the Leverage Still Worth the Complexity?

Strategy Inc (NASDAQ:MSTR) rallied along with Bitcoin. The cryptocurrency rally followed a White House meeting with industry executives, while the Treasury Department’s expanded bond-buyback plans lowered long-term yields and weakened the dollar. However, Strategy Inc (NASDAQ:MSTR) is not a simple leveraged Bitcoin fund. The company held 843,775 Bitcoin on July 26, sold 1,638 Bitcoin during […]

Affirm (NASDAQ:AFRM) Delivers Strong Q2 CY2026 Numbers, Stock Soars
StockStory30d agobullish
Affirm (NASDAQ:AFRM) Delivers Strong Q2 CY2026 Numbers, Stock Soars

Buy now, pay later company Affirm (NASDAQ:AFRM) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 33% year on year to $1.17 billion. On top of that, next quarter’s revenue guidance ($1.21 billion at the midpoint) was surprisingly good and 3.6% above what analysts were expecting. Its GAAP profit of $4.62 per share was significantly above analysts’ consensus estimates.

Does Keysight’s Raised Outlook and AI Design Wins Change The Bull Case For Keysight Technologies (KEYS)?
Simply Wall St.30d agobullish
Does Keysight’s Raised Outlook and AI Design Wins Change The Bull Case For Keysight Technologies (KEYS)?

In August 2026, Keysight Technologies reported third-quarter sales of US$1,846 million and net income of US$397 million, raised its fourth-quarter 2026 revenue outlook to between US$1.93 billion and US$1.95 billion, and announced Scott Reese’s appointment to its board with roles on the Nominating, Corporate Governance, Audit, and Finance Committees. Keysight also highlighted expanding adoption of its EDA software, with AttoTude Inc. reporting design cycle times cut by more than half and...

Almonty (ALM) Authorized a $300M Buyback Before Sangdong Fully Ramps. Is that the Best Use of Capital?
Insider Monkey30d agobullish
Almonty (ALM) Authorized a $300M Buyback Before Sangdong Fully Ramps. Is that the Best Use of Capital?

Almonty Industries Inc. (NASDAQ:ALM) began a 36-month share-repurchase authorization on August 24 that permits the company to buy up to 14.4 million common shares, representing approximately 5% of shares outstanding as of August 14, for as much as US$300 million. The headline amount overstates what Almonty Industries Inc. (NASDAQ:ALM) would spend at its current valuation. […]

Marvell tops Q2 estimates as data center revenue jumps 46%
Proactive30d agobullish
Marvell tops Q2 estimates as data center revenue jumps 46%

Marvell Technology Inc (NASDAQ:MRVL)'s second-quarter revenue rose 37% year-over-year to $2.7 billion, topping analyst estimates of $2.71 billion, as demand for its data center chips continued to accelerate. Adjusted earnings per share came in at $0.94, up 40% from a year earlier and ahead of...